dc.creatorVelavan, Thirumalaisamy P.
dc.creatorMeyer, Christian G.
dc.date.accessioned2020-10-21T17:42:41Z
dc.date.accessioned2022-09-23T18:23:42Z
dc.date.available2020-10-21T17:42:41Z
dc.date.available2022-09-23T18:23:42Z
dc.date.created2020-10-21T17:42:41Z
dc.identifier1201-9712
dc.identifierhttps://doi.org/10.1016/j.ijid.2020.10.034
dc.identifierhttp://hdl.handle.net/20.500.12010/14663
dc.identifierhttps://doi.org/10.1016/j.ijid.2020.10.034
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3500019
dc.description.abstractThe current literature gives indications of the median duration of virus shedding of 11.5 days for pre-symptomatic, 28 days for asymptomatic and 31 days for mildly symptomatic patients (Li et al. 2020). Another study using the similar gene target ORF1ab as described by Malagón-Rojas et al. shows that median Ct values during hospitalization were significantly higher in asymptomatic patients (39.0, IQR 37.5- 39.5) than in asymptomatic patients during the incubation period (34.5, IQR 32.2- 37.0), indicating a significantly lower viral load (Zhou et al. 2020). Long-term virus shedding was documented rather in asymptomatic than in symptomatic patients and virus shedding did not correspond to viral infectivity (Long et al. 2020)
dc.languageeng
dc.publisherInternational Journal of Infectious Diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectAsymptomatic
dc.subjectPresymptomatic
dc.subjectCase definition
dc.subjectCOVID-19
dc.subjectARS-CoV2
dc.titleReply to: Asymptomatic infection by SARS 2 coronavirus: invisible but invincible


Este ítem pertenece a la siguiente institución